Oric Pharmaceuticals (ORIC) Retained Earnings (2019 - 2026)
Oric Pharmaceuticals (ORIC) posted Retained Earnings of -$728.0 million for Q1 2026, down 5.17% on a QoQ basis from -$692.2 million in Q4 2025, and down 348425.36% year-over-year from N/an in Q1 2025.
Oric Pharmaceuticals (ORIC) Retained Earnings (2019 - 2026) Analysis & Trends
Oric Pharmaceuticals' Retained Earnings history runs 8 years deep, the most recent figure standing at -$728.0 million for Q1 2026.
- Quarterly Retained Earnings fell 348425.36% year-over-year to -$728.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$728.0 million (down 348425.36% YoY) and the FY2025 annual result came in at -$692.2 million, down 23.01% from the prior year.
- Retained Earnings was -$728.0 million for Q1 2026 at Oric Pharmaceuticals, down from -$692.2 million in the prior quarter.
- Across five years, Retained Earnings topped out at $209000.0 in Q1 2025 and bottomed at -$728.0 million in Q1 2026.
- A 5-year average of -$385.7 million and a median of -$434.9 million in 2023 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2025 — Retained Earnings soared 100.05% — and 2026, when it sank 348425.36%.
- Oric Pharmaceuticals' Retained Earnings stood at -$1.3 million in 2022, then slumped by 33589.16% to -$434.9 million in 2023, then fell by 29.4% to -$562.8 million in 2024, then declined by 23.01% to -$692.2 million in 2025, then dropped by 5.17% to -$728.0 million in 2026.
- Business Quant data shows ORIC's Retained Earnings at -$728.0 million in Q1 2026, -$692.2 million in Q4 2025, and -$661.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Oric Pharmaceuticals | 1.15 Bn | 866.67 Mn | - | -728.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -728.00 Mn |
| Dec 31, 2025 | -692.24 Mn |
| Sep 30, 2025 | -661.70 Mn |
| Jun 30, 2025 | -629.20 Mn |
| Mar 31, 2025 | 209,000.00 |
| Dec 31, 2024 | -562.77 Mn |
| Sep 30, 2024 | -526.50 Mn |
| Jun 30, 2024 | -491.90 Mn |
| Mar 31, 2024 | -459.94 Mn |
| Dec 31, 2023 | -434.93 Mn |
| Sep 30, 2023 | -406.60 Mn |
| Jun 30, 2023 | -567,000.00 |
| Mar 31, 2023 | -358.18 Mn |
| Dec 31, 2022 | -1.29 Mn |
| Sep 30, 2022 | -313.38 Mn |
| Jun 30, 2022 | -288.55 Mn |
| Mar 31, 2022 | -802,000.00 |
| Dec 31, 2021 | -245.11 Mn |
| Sep 30, 2021 | -222.34 Mn |
| Jun 30, 2021 | -203.90 Mn |